Drugs Made In America Acquisition II Corp. (DMII) Institutional Ownership

Ownership Summary

Drugs Made In America Acquisition II Corp. (NASDAQ:DMII) has 51 institutional investors that have filed 13F reports for the period ending December 2025.

• They increased total shares held in Drugs Made In America Acquisition by 0.0% from last quarter, and the number of investors in DMII stayed flat annually.
• Of these 51 holders, 51 added to their stakes in Drugs Made In America Acquisition, 0 trimmed positions, and 0 made no changes.
• In total, institutional investors held 35.06Mn shares in Drugs Made In America Acquisition as of December 2025, up by 35.06Mn shares quarter on quarter, and with no net change year over year.
• As of December 31, 2025, Magnetar Financial LLC held the largest stake in Drugs Made In America Acquisition with 2.7Mn shares, accounting for 17.67% of total shares outstanding.
• The most significant purchases of DMII for the quarter ending December 2025 came from MMCAP International Inc. SPC (2.7Mn), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (2.0Mn), Karpus Management, Inc. (1.45Mn), Mercuria Capital Strategies, LLC (750.0K), WOLVERINE ASSET MANAGEMENT LLC (732.52K).
• The largest sales of DMII for the quarter ending December 2025 came from First Trust Capital Management L.P. (1.0Mn), CSS LLC/IL (695.96K), Lineage Point Capital LP (336.36K), MIZUHO SECURITIES USA LLC (197.71K), Clear Street Group Inc. (166.18K).
• Drugs Made In America Acquisition's 10 largest shareholders as of December 2025 include Magnetar Financial LLC (2.7Mn), MMCAP International Inc. SPC (2.7Mn), Karpus Management, Inc. (2.6Mn), GLAZER CAPITAL, LLC (2.35Mn), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (2.0Mn), MILLENNIUM MANAGEMENT LLC (1.98Mn), Hudson Bay Capital Management LP (1.97Mn), WOLVERINE ASSET MANAGEMENT LLC (1.8Mn), Polar Asset Management Partners Inc. (1.5Mn), TENOR CAPITAL MANAGEMENT Co., L.P. (1.5Mn) per Business Quant data.